Feb. 17, 2021 06:00 UTC
ST PREX, Switzerland & ROSEVILLE, Minn. & ROHOVOT, Israel--(BUSINESS WIRE)-- Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility.1,2,3 The collaboration is an important step forward in harnessing the power of the human microbiome in this area of womens health.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210216006205/en/
Currently bacterial vaginosis is treated with antibiotics, which can disrupt the vaginal microbiome, and its common for bacterial vaginosis to return following treatment.4 The aim of a microbiota-based treatment would be to reduce the need for antibiotic use and provide a long-term treatment solution.
The multi-year agreement combines MyBiotics unique culturing, delivery and colonisation technologies aimed at restoring microbiome equilibrium with Rebiotixs expertise in developing clinical-stage live microbiota-based biotherapeutic products and Ferrings therapeutic development and commercial expertise. The new agreement builds on the existing collaboration between Ferring and MyBiotics, initiated in 2017, which has already successfully piloted technologies intended to stabilise selected bacterial species critical to the health of the female reproductive tract using MyBiotics' MyCrobe technology.
We are proud to be undertaking this collaboration, as it is a critical step forward in meeting patient needs through the potential of the microbiome, said Ken Blount, Chief Scientific Officer, Rebiotix and Vice President of Microbiome Research, Ferring Pharmaceuticals. This collaboration with MyBiotics not only harnesses our collective expertise in developing live microbiota-based biotherapeutic technologies, but also reaffirms Ferrings deep commitment to building families worldwide through innovations in reproductive medicine and maternal health.
The collaboration announced today also stands to add several firsts to Ferrings microbiome product pipeline, including the companys first non-donor derived formulation, and a live microbiota-based product specific to reproductive medicine.
Todays agreement is an important evolution of our long-standing relationship with Ferring in the field of microbiota-based therapies for the benefit of women's health, including reproduction and pregnancy, said MyBiotics CEO, David Daboush. We look forward to combining our innovative MyCrobe live bacteria culturing, delivery and colonisation technology with the world-leading development experience of Rebiotix for the benefit of women. The collaboration with Rebiotix builds on our successful collaboration with Ferring, and we are excited to build on that strong relationship targeted to bringing novel treatments to patients through our tailor-made microbiome technology platform.
MyBiotics has developed breakthrough and robust culturing, fermentation and delivery technologies for generating a highly stable and diverse bacterial community that can be efficiently delivered to different sites across the human body for restoring microbiome equilibrium. These technologies are effective for single microbes, complex microbial consortia and whole microbiome products, and are integrated with a computational AI platform, which enables the design of unique microbial consortia and whole microbiome profiles. The technologies are highly potent and suitable for patients with microbiome-related medical conditions.
The potential of live microbiota-based biotherapeutic products is an expanding frontier. The most clinically advanced formulations, derived from the human gut microbiome, are currently being developed to address Clostridioides difficile (C.diff) infection and have opened the door to harnessing the power of the microbiome to address other unmet medical needs. As the future of microbiome-based therapeutics expands, the potential extends beyond the gut to reproductive medicine. The ability to generate standardised, stabilised, approved formulations, created to serve patient needs in reproductive medicine and maternal health, connects to the core vision of both companies.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and womens health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
Learn more at http://www.ferring.com, or connect with us on Twitter, Facebook, Instagram, LinkedIn and YouTube.
About Rebiotix
Rebiotix Inc, a Ferring Company, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionise the treatment of challenging diseases. Rebiotix brings a diverse pipeline of investigational drug products to Ferrings portfolio built on its pioneering microbiota-based MRT drug platform. The platform consists of investigational drug technologies designed to potentially rehabilitate the human microbiome by delivering a broad consortium of live microbes into a patients intestinal tract. For more information on Rebiotix and its pipeline of human microbiome-directed therapies for diverse disease states, visit http://www.rebiotix.com, or connect with us on Twitter, Facebook, LinkedIn and YouTube.
About MyBiotics
MyBiotics discovers and develops microbiome-based products aimed at restoring microbiome equilibrium for the therapeutics and food markets. MyBiotics' technologies are effective for single microbes, complex microbial consortia and whole microbiome products, and are integrated with a computational AI platform which enables the design of unique microbial consortia and whole microbiome profiles. The company's pipeline includes products targeted at infectious diseases, woman's health, gastro and oncology indications, as well as probiotics and prebiotic programs. For additional information, please visit http://www.mybiotics-pharma.com or connect with us on LinkedIn.
References:
1 Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis [Internet]. Sexually transmitted diseases. U.S. National Library of Medicine; [cited 2021 Feb 2]. Available from: https://pubmed.ncbi.nlm.nih.gov/30624309/
2 Giakoumelou S et al. The role of infection in miscarriage. Human Reproduction Update 2016;22:116133. doi.org/10.1093/humupd/dmv041. Last accessed February 2021
3 Bacterial vaginosis and pregnancy. March of Dimes. Available at: https://www.marchofdimes.org/complications/bacterial-vaginosis.aspx. Last accessed February 2021
4 Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004;80:811. doi:10.1136/sti.2002.002733. Last accessed February 2021
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216006205/en/
See the article here:
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health - BioSpace
- One in 10 Ohio women thought abortion illegal amid attempts to ban at 6 weeks - The Ohio State University News - February 17th, 2021
- Bia-Echo Foundation invest $8M in Singapore to study women's reproductive longevity - BSA bureau - February 17th, 2021
- Now is the Time for the Biden Administration to Commit to Upholding Reproductive Rights as Human Rights - Just Security - February 17th, 2021
- Severe Physical Intimate Partner Violence Linked to Mental Disorders in Black Women - Psychiatry Advisor - February 17th, 2021
- $21.6 Billion Feminine Hygiene Products Markets - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast to 2026 -... - February 17th, 2021
- Genitourinary Syndrome of Menopause is Overlooked and Undertreated - Contemporary Obgyn - February 17th, 2021
- Menstrual cycles and lunar cycles: Is there a link? - Medical News Today - February 17th, 2021
- It's Time to Take the Penis off Its Pedestal - Scientific American - February 16th, 2021
- 'This has to stop': NC leaders call for legislation to address Black maternal health crisis - The Fayetteville Observer - February 16th, 2021
- Simple, accurate and evidence-based: U of T experts create women's health resource - News@UofT - February 16th, 2021
- The White House Is Taking Womens Issues Seriously. Really. - The New York Times - February 16th, 2021
- Customary and religious laws are impeding progress towards women's health in Nigeria - The Conversation CA - February 16th, 2021
- Flo Health Surveyed nearly 3,500 Women to Find out how the Pandemic Has Impacted Sexual Desire, Relationship Quality, and Mental Health - PRNewswire - February 16th, 2021
- A brief history of the menopause taboo - goodhousekeeping.com - February 16th, 2021
- Reproductive rights face increasing threats no matter what actions President Biden takes | Letters - Chicago Sun-Times - February 16th, 2021
- EXCLUSIVE: PCOS and Exercise: What is the connection and all that you need to know about it - PINKVILLA - February 16th, 2021
- Lancet hails reproductive health activist Rani Bang, calls her initiative model for rest of the world - The Indian Express - February 16th, 2021
- How rooibos can benefit reproductive health in both men and women - IOL - February 16th, 2021
- Know with the flow: Fact-checking Libras pad trivia - The Spinoff - February 16th, 2021
- Why research and conversation about menopause is letting down Black and Asian people - goodhousekeeping.com - February 16th, 2021
- Gender and punishment - The Indian Express - February 16th, 2021
- New WHO report reveals urgency of confronting tobacco use among women - WHO/Europe - February 16th, 2021
- Mystery around bears' reproduction is a reminder of their balancing act - Minneapolis Star Tribune - February 4th, 2021
- A New Era for Women: The Biden Administration's Vision on Health Care and Reproductive Rights - Ms. Magazine - February 4th, 2021
- US anti-abortion "gag rule" hits women hard: what we found in Kenya and Madagascar - The Conversation Africa - February 4th, 2021
- Letter: Comparing reproductive rights to slavery is a false equivalency - Berkshire Eagle - February 4th, 2021
- As global cases of COVID-19 hit grim milestones and exacerbate other crises, UNFPA strengthens resolve to save lives - World - ReliefWeb - February 4th, 2021
- Gynecological oncologist addressing disparities for Black and Hispanic women - FOX 7 Austin - February 4th, 2021
- Thousands Join Global Call for Universal Access to Reproductive Health at 'Not Without FP' Virtual Forum - PRNewswire - February 4th, 2021
- COVID vaccines and pregnancy: informed decision-making for women - UAB News - February 4th, 2021
- President Biden Expands Access to Affordable Care Act Exchange Plans, Womens Reproductive Health - JD Supra - February 4th, 2021
- Misinformation between COVID vaccine and infertility raises alarm - WTOP - February 4th, 2021
- Violation of her reproductive health rights - Afghanistan - ReliefWeb - February 4th, 2021
- The Expert Guide To Taking Care Of Your Reproductive Health - Femina - February 4th, 2021
- Mental Health Monday Maternal Mental Health: Education and Advocacy Through Comedy - Hoover Sun - February 4th, 2021
- Governor Cuomo Reminds Surrogates and Parents of Their New Insurance Rights and Protections During Gestational Surrogacy - ny.gov - February 4th, 2021
- Announcing the Passing of Charles B. Hammond, MD, Professor & Chair Emeritus - Duke Today - February 4th, 2021
- What is the real cost of infertility in Tennessee? - WBIR.com - February 4th, 2021
- Lawsuit challenges FDA approval of additive that makes Impossible Burger 'bleed' - Food Safety News - February 4th, 2021
- A newly discovered chameleon less than an inch long could be the world's smallest reptile - CNN - February 4th, 2021
- Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages - National Institutes of Health - January 31st, 2021
- Women's reproductive healthcare in Asia gets boost with first at-home blood-testing kit for female fertility - Yahoo Finance - January 31st, 2021
- Your App Knows You Got Your Period. Guess Who It Told? - The New York Times - January 31st, 2021
- Meeting the urgent needs of vulnerable women and girls and those displaced by violence in Cabo Delgado joint UN mission - Mozambique - ReliefWeb - January 31st, 2021
- Women's Menstrual Cycles Tied to Moon's Phases - HealthDay News - January 31st, 2021
- Evidence Builds That Pregnant Women Pass Covid Antibodies to Newborns - The New York Times - January 31st, 2021
- Argentina's legalisation of abortion is only the beginning of the battle for reproductive rights in Latin America | LSE Latin America and Caribbean -... - January 31st, 2021
- The horrors of Auschwitz - Deccan Herald - January 31st, 2021
- Addressing the Fragile Limits of Female Autonomy - Fair Observer - January 31st, 2021
- Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women... - January 31st, 2021
- President Joseph R. Biden Signs Memorandum on Protecting Women's Health at Home and Abroad - Sierra Sun Times - January 31st, 2021
- Developing investment cases for transformative results - World - ReliefWeb - January 31st, 2021
- Chinese millennials aren't getting married, and the government is worried - CNN - January 31st, 2021
- Legacy of shame: Linnea Dunne on why she started a podcast about the women's health issues society won't discuss - Independent.ie - January 31st, 2021
- Honduras must reject reform that perpetuates the criminalization of abortion - Amnesty International - January 31st, 2021
- Can a Dalit man and an upper-caste woman be in love? Another thing Tandav gets wrong - ThePrint - January 31st, 2021
- Student casts light on dark issue plaguing South Asian women: 'A really difficult thing to talk about' - Yahoo Movies Canada - January 31st, 2021
- Towards a Feminist Political Economy in the MENA Region [EN/AR] - World - ReliefWeb - January 31st, 2021
- The secret to healthy menses for women! - Times Now - January 31st, 2021
- Houston, We Have a Baby - NEO.LIFE - January 15th, 2021
- Yayasan Rama Sesana and the Quest for Female Reproductive Health in Bali - Global Risk Insights - January 15th, 2021
- Kenya announces successful creation of 2 northern white rhino embryos - cgtn.com - January 15th, 2021
- The State of Women's LeadershipAnd How To Continue Changing the Face of US Politics - Center For American Progress - January 15th, 2021
- NOW-NJ: New Jerseyans Need the Reproductive Freedom Act Now - InsiderNJ - January 15th, 2021
- Ditto Reproduction May Have Disturbing Implications for Pokemon Breeding - CBR - Comic Book Resources - January 15th, 2021
- Argentina officially legalises abortion as women in Chile protest for reproductive rights - SBS News - January 15th, 2021
- Here's what we know sex with Neanderthals was like - BBC News - January 15th, 2021
- Daily ovarian cancer pill is biggest breakthrough in 30 YEARS and slows disease by up to a year - The Irish Sun - January 15th, 2021
- Pfizer's XALKORI (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults - Business Wire - January 15th, 2021
- Legislators will again try to repeal antiquated abortion ban - New Mexico Political Report - January 15th, 2021
- Olive Leaf Extract Inhibits Breast and Ovarian Cancer Cell Growth and Cell Cycle Progression, Increasing Apoptosis of Tumor Cells - Newswise - January 4th, 2021
- Popular section of Banff National Park remains closed to protect possibly pregnant grizzly bear - CBC.ca - January 4th, 2021
- UPDATE - Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women's... - January 4th, 2021
- What might it have meant to marry Jesus while trying to be break free as a woman? Try this novel - Scroll.in - January 4th, 2021
- Giant pandas at Edinburgh Zoo may have to return to China - Sky News - January 4th, 2021
- Senator Rasha Kelej, CEO of Merck Foundation named among Most Influential African Woman in the world, as African Woman of the year 2020, for the third... - January 4th, 2021
- Feminist Wishes for 2021: Continuing the Fight - Ms. Magazine - January 4th, 2021
- Burning sensation in lower abdomen: Causes and treatments - Medical News Today - December 23rd, 2020
- What Will It Take to Get a Black Woman on the Supreme Court? - New York Magazine - December 23rd, 2020
- Sticky discharge: Causes, treatment, and when to see a doctor - Medical News Today - December 23rd, 2020